Antimicrobials · Beta-lactam/Beta-lactamase Inhibitor Combinations
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Ampicillin-sulbactam is a beta-lactam/beta-lactamase inhibitor combination that expands the spectrum of ampicillin to include beta-lactamase-producing organisms.
The primary clinical indication for ampicillin-sulbactam is the treatment of aspiration pneumonia and lung abscesses due to its excellent coverage of anaerobic bacteria and oral flora.
Ampicillin-sulbactam provides robust coverage against methicillin-susceptible Staphylococcus aureus (MSSA), but it lacks activity against methicillin-resistant Staphylococcus aureus (MRSA).
This agent is a first-line treatment for intra-abdominal infections and gynecologic infections where polymicrobial coverage is required.
Sulbactam acts as a suicide inhibitor that irreversibly binds to and inactivates bacterial beta-lactamases, protecting ampicillin from degradation.
Ampicillin-sulbactam is frequently utilized for the treatment of skin and soft tissue infections involving diabetic foot ulcers or bite wounds.
The most common adverse effects of ampicillin-sulbactam include diarrhea, nausea, and the potential for hypersensitivity reactions characteristic of the penicillin class.
Vignette unlocked
A 68-year-old male with a history of stroke and dysphagia presents to the emergency department with a three-day history of fever, productive cough with foul-smelling sputum, and pleuritic chest pain. Physical examination reveals crackles in the right lower lobe and poor dentition. A chest X-ray demonstrates a cavitary lesion in the right lower lobe with an air-fluid level. The patient is hemodynamically stable.
Which of the following is the most appropriate empiric antibiotic therapy for this patient?
Ampicillin-sulbactam
The patient's presentation of aspiration pneumonia with a lung abscess requires coverage for anaerobic organisms, for which ampicillin-sulbactam is a high-yield, first-line choice.
Full handout
High yield triage
Classification
Combination aminopenicillin and beta-lactamase inhibitor.
Indications
Aspiration pneumonia, intra-abdominal infections, and gynecologic infections.
Mechanism of Action
Inhibits bacterial cell wall synthesis; sulbactam prevents beta-lactamase degradation.
Side Effects
Diarrhea, nausea, anaphylaxis, Clostridioides difficile colitis.
Contraindications / Monitoring
History of penicillin allergy. Monitor renal function and CBC.
Full handout
Mechanism of Action
Ampicillin binds to penicillin-binding proteins (PBPs), inhibiting cross-linking of the peptidoglycan cell wall. Sulbactam acts as a suicide inhibitor of beta-lactamases, protecting ampicillin from enzymatic hydrolysis. This synergy expands the spectrum to include beta-lactamase-producing organisms.
Unique Properties
Unlike standard ampicillin, this combination provides coverage against anaerobes and Staphylococcus aureus (MSSA). It is the parenteral equivalent to oral amoxicillin-clavulanate.
Indications
Used for aspiration pneumonia due to excellent anaerobic coverage. Also indicated for intra-abdominal infections (e.g., peritonitis) and gynecologic infections (e.g., endometritis). Often used as empiric therapy for skin and soft tissue infections.
Pharmacokinetics
Excreted primarily via the kidneys. Requires dose adjustment in patients with significant renal impairment to prevent accumulation and neurotoxicity.
Side Effects & Adverse Events
Common effects include diarrhea and nausea. Anaphylaxis is a rare but life-threatening hypersensitivity reaction. Prolonged use carries a high risk for Clostridioides difficile colitis due to broad-spectrum gut flora disruption.
Contraindications
History of severe hypersensitivity (anaphylaxis) to any penicillin is an absolute contraindication. History of cholestatic jaundice or hepatic dysfunction associated with previous beta-lactamase inhibitor use.
Monitoring
Monitor serum creatinine and BUN to guide dosing. Perform periodic CBC to screen for leukopenia or thrombocytopenia during prolonged courses.
Clinical Pearls
Think of this as the go-to for aspiration pneumonia in the hospital setting. It is a classic board answer for patients with mixed aerobic/anaerobic infections where Bacteroides fragilis is a concern.